Simple Assessment of Cerebral Hemodynamics Using Single-Slab 3D Time-of-Flight MR Angiography in Patients with Cervical Internal Carotid Artery Steno-Occlusive Diseases: Comparison with Quantitative Perfusion Single-Photon Emission CT

References

1. ↵
   Gibbs JM, Wise RJ, Leenders KL, et al. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet 1984;1:310–14

   CrossRefPubMedWeb of Science
2. ↵
   Powers WJ, Raichle ME. Positron emission tomography and its application to the study of cerebrovascular disease in man. Stroke 1985;16:361–76

   FREE Full Text
3. ↵
   Ringelstein EB, Grosse W, Matentzoglu S, et al. Non-invasive assessment of the cerebral vasomotor reactivity by means of transcranial Doppler sonography during hyper- and hypocapnea. Klin Wochenschr 1986;64:194–95

   CrossRefPubMed
4. ↵
   Ringelstein EB, Van Eyck S, Mertens I. Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamide. J Cereb Blood Flow Metab 1992;12:162–68

   CrossRefPubMedWeb of Science
5. ↵
   Nemoto EM, Yonas H, Kuwabara H, et al. Identification of hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease. J Cereb Blood Flow Metab 2004;24:1081–89

   PubMed
6. ↵
   Yamauchi H, Okazawa H, Kishibe Y, et al. Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease. J Neurol Neurosurg Psychiatry 2004;75:33–37

   Abstract/FREE Full Text
7. ↵
   Kuroda S, Houkin K, Kamiyama H, et al. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001;32:2110–16

   Abstract/FREE Full Text
8. ↵
   Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke 2002;33:1857–62

   Abstract/FREE Full Text
9. ↵
   Yonas H, Smith HA, Durham SR, et al. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 1993;79:483–89

   CrossRefPubMedWeb of Science
10. ↵
    Hosoda K, Kawaguchi T, Shibata Y, et al. Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy. Stroke 2001;32:1567–73

    Abstract/FREE Full Text
11. ↵
    Ogasawara K, Yukawa H, Kobayashi M, et al. Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy by using single-photon emission computerized tomography scanning. J Neurosurg 2003;99:504–10

    PubMedWeb of Science
12. ↵
    Piepgras DG, Morgan MK, Sundt TM Jr, et al. Intracerebral hemorrhage after carotid endarterectomy. J Neurosurg 1988;68:532–36

    CrossRefPubMedWeb of Science
13. Ogasawara K, Yamadate K, Kobayashi M, et al. Postoperative cerebral hyperperfusion associated with impaired cognitive function in patients undergoing carotid endarterectomy. J Neurosurg 2005;102:38–44

    PubMedWeb of Science
14. ↵
    Ogasawara K, Sakai N, Kuroiwa T, et al. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: retrospective review of 4494 patients. J Neurosurg 2007;107:1130–36

    CrossRefPubMedWeb of Science
15. ↵
    Kim JH, Lee SJ, Shin T, et al. Correlative assessment of hemodynamic parameters obtained with T2*-weighted perfusion MR imaging and SPECT in symptomatic carotid artery occlusion. AJNR Am J Neuroradiol 2000;21:1450–56

    Abstract/FREE Full Text
16. ↵
    Kikuchi K, Murase K, Miki H, et al. Quantitative evaluation of mean transit times obtained with dynamic susceptibility contrast-enhanced MR imaging and with (133)Xe SPECT in occlusive cerebrovascular disease. AJR Am J Roentgenol 2002;179:229–35

    PubMed
17. ↵
    Hirano T, Minematsu K, Hasegawa Y, et al. Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters. J Cereb Blood Flow Metab 1994;14:763–70

    CrossRefPubMedWeb of Science
18. ↵
    Wardlaw JM, Dennis MS, Merrick MV, et al. Relationship between absolute mean cerebral transit time and absolute mean flow velocity on transcranial Doppler ultrasound after ischemic stroke. J Neuroimaging 2002;12:104–11

    PubMed
19. ↵
    Naylor AR, Merrick MV, Slattery JM, et al. Parametric imaging of cerebral vascular reserve: 2. Reproducibility, response to CO2 and correlation with middle cerebral artery velocities. Eur J Nucl Med 1991;18:259–64

    PubMed
20. ↵
    Marchal G, Bosmans H, Van Fraeyenhoven L, et al. Intracranial vascular lesions: optimization and clinical evaluation of three-dimensional time-of flight MR angiography. Radiology 1990;175:443–48

    PubMed
21. ↵
    Davis WL, Blatter DD, Harnsberger HR, et al. Intracranial MR angiography: comparison of single-volume three-dimensional time-of-flight and multiple overlapping thin slab acquisition techniques. AJR Am J Roentgenol 1994;163:915–20

    PubMed
22. ↵
    Kodama T, Watanabe K. Influence of imaging parameters, flow velocity, and pulsatile flow on three-dimensional time-of-flight MR angiography: experimental studies. Eur J Radiol 1997;26:83–91

    CrossRefPubMed
23. ↵
    North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445–53

    CrossRefPubMedWeb of Science
24. ↵
    Ogasawara K, Ito H, Sasoh M, et al. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H₂ ¹⁵O with PET. J Nucl Med 2003;44:520–25

    Abstract/FREE Full Text
25. ↵
    Iida H, Itoh H, Nakazawa M, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med 1994;35:2019–30

    Abstract/FREE Full Text
26. ↵
    Friston KJ, Frith CD, Liddle PF, et al. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 1990;10:458–66

    PubMedWeb of Science
27. ↵
    Takeuchi R, Matsuda H, Yoshioka K, et al. Cerebral blood flow SPET in transient global amnesia with automated ROI analysis by 3DSRT. Eur J Nucl Med Mol Imaging 2004;31:578–89

    CrossRefPubMedWeb of Science
28. ↵
    Fleiss JL. Statistical Methods for Rates and Proportions. New York: Wiley;1981
29. ↵
    Bernstein MA, Huston J 3rd, Lin C, et al. High-resolution intracranial and cervical MRA at 3.0T: technical considerations and initial experience. Magn Reson Med 2001;46:955–62

    CrossRefPubMedWeb of Science
30. ↵
    Thomas SD, Al-Kwifi O, Emery DJ, et al. Application of magnetization transfer at 3.0 T in three-dimensional time-of-flight magnetic resonance angiography of the intracranial arteries. J Magn Reson Imaging 2002;15:479–83

    CrossRefPubMed
31. ↵
    Derick RJ. Carbonic anhydrase inhibitors. In: Mauger TF, Craig EL, eds. Hevener's Ocular Pharmacology. 6th ed. St Louis: CV Mosby;1994 :56–60
32. ↵
    Ogasawara K, Tomitsuka N, Kobayashi M, et al. Stevens-Johnson syndrome associated with intravenous acetazolamide administration for evaluation of cerebrovascular reactivity. Case report. Neurol Med Chir (Tokyo) 2006;46:161–63

    CrossRefPubMed
33. ↵
    Kikuchi K, Murase K, Miki H, et al. Measurement of cerebral hemodynamics with perfusion-weighted MR imaging: comparison with pre- and post-acetazolamide 133Xe-SPECT in occlusive carotid disease. AJNR Am J Neuroradiol 2001;22:248–54

    Abstract/FREE Full Text
34. ↵
    Endo H, Inoue T, Ogasawara K, et al. Quantitative assessment of cerebral hemodynamics using perfusion-weighted magnetic resonance imaging in patients with major cerebral artery occlusive disease: comparison with positron emission tomography. Stroke 2006;37:388–92

    Abstract/FREE Full Text
35. ↵
    Wiginton CD, Kelly B, Oto A, et al. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR Am J Roentgenol 2008;190:1060–68

    CrossRefPubMedWeb of Science